Innovative Wound Care Technology ProgenaCare's proprietary human keratin matrix, ProgenaMatrix, offers a unique medical device solution for complex wound management, presenting a compelling value proposition for healthcare providers seeking advanced, effective, and cost-efficient wound healing options.

Global Expansion Opportunities With recent office expansions into the Middle East, Uganda, and Rwanda, ProgenaCare is actively increasing its international footprint, opening avenues for sales partnerships and distribution channels in emerging markets with expanding healthcare infrastructure.

Strong Industry Recognition Named the 2023 Global Exporter of the Year, ProgenaCare demonstrates credibility and market leadership potential, making it an attractive partner for distributors and health systems looking for innovative wound care solutions.

Strategic Partnerships Collaborations such as the partnership with Kane Biotech for the launch of Revyve Antimicrobial Wound Gel highlight opportunities for joint product offerings and co-marketing strategies to penetrate broader wound care markets.

Focus on Patient Access ProgenaCare’s CaringAccess Patient Assistance Program underscores a commitment to affordability and access, which can be leveraged in outreach efforts to healthcare facilities serving underserved populations or those emphasizing value-based care.